Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitabar Diabetes
- Development stage
- Unknown
- Lead developer
- Barakat Pharmaceutical Industries
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Vitabar Diabetes is a specialized multi-vitamin and mineral supplement developed by Barakat Pharmaceutical Industries (BPI) to address the specific nutritional requirements of individuals with diabetes. Formulated with 20 essential vitamins and minerals, the product aims to provide comprehensive nutritional support tailored to the metabolic needs of diabetic patients. As a nutritional supplement rather than a therapeutic pharmaceutical, it does not target a specific biological pathway but rather serves as an adjunct to diabetes management by preventing or correcting micronutrient deficiencies.
- Brand names
- Vitabar Diabetes
Beyond the preview
Go deeper on Vitabar Diabetes.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitabar Diabetes.